According to a recent report http://video.msnbc.msn.com/nightly-news/48772167/, the NIH was plagued with a deadly bacteria strain known as a superbug and despite extraordinary steps such as walling off patients and removing the plumbing, they were unable to prevent several patient deaths do the contamination. NIH is one of the best medical centers in America, and the acknowledgement of this bacteria strain has highlighted the need for better treatments and therapies for nosocomial infections.
The solution is partially to be found in new antibacterial treatments. But developments have been slow and pharmaceutical industries need better incentives to produce antibacterials, according to our latest report on AntiInfectives report.
Testing is also important as hospitals struggle to determine which patients to isolate. Fast results from molecular tests have led the way. Kalorama's recent report, Hospital Acquired Infections: Testing Markets details the developments in the market for nosocomial diagnostics.
Friday, August 24, 2012
Tuesday, August 21, 2012
Walmart is currently in third place in terms of number of retail clinics, eclipsed by Walgreens and CVS. However that statistic fails to take into account that all Walgreens stores and all CVS stores are obviously drug stores, while not every Walmart has a pharmacy. Kalorama Information's report on retail clinics: Retail Clinics 2011: Growth of Stores, Best Venues, Winning Competitors, Supplier Sales of Products to Clinics, Clinic Sales Forecasts and Trends has concluded that drug stores are the most viable locations.
When we look at percentage of retail clinics in drug stores, we can see that Walgreens is far in the lead and Walmart is only slightly behind (seven-tenths of a percent) CVS. They are operating in the zone of competition now with the two giants. Of course, time will tell if this commitment to stores continues.